First-half revenue and operating income exceeded initial forecasts, driven particularly by growth in the semiconductor business. Full-year operating margin was revised upward to 13.2%. To mitigate downside risk in Healthcare from rising raw material costs, the company is reviewing trading terms and exploring new procurement sources. Additional investment in Faraday rotors was approved in October, with planned phased increases in production capacity. In new domains, growth and demand expansion in quantum-related areas are expected, and a medium-term plan through fiscal 2029 is being advanced.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6521","jir_company_name":"OXIDE Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-19","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/6521-20261019-01.pdf","jir_short_summary":"First-half revenue and operating income exceeded initial forecasts, driven particularly by growth in the semiconductor business. Full-year operating margin was revised upward to 13.2%. To mitigate downside risk in Healthcare from rising raw material costs, the company is reviewing trading terms and exploring new procurement sources. Additional investment in Faraday rotors was approved in October, with planned phased increases in production capacity. In new domains, growth and demand expansion in quantum-related areas are expected, and a medium-term plan through fiscal 2029 is being advanced.","jir_summary":"### Overview of Performance\nThis document summarizes the key points from the earnings presentation held on October 16, 2026, explaining that the upside in first-half revenue and operating income was driven by corporate growth and improved profitability. In particular, the semiconductor business contributed strong growth and high margin impact, and profit uplift was also driven by cost controls and operational efficiency improvements. The full-year operating margin was revised upward to 13.2%, indicating a maintained balance between growth strategy and investment. For the Healthcare division's downside risk, the company intends to respond to rising raw material prices by reviewing trading terms and considering new procurement sources. The additional investment in Faraday rotors aims to expand production capacity and capture demand, and growth initiatives in new areas including quantum are being continued.\n\n### Outlook and Main Focus Areas\nThe semiconductor business has solid order momentum and the current production system is considered capable of meeting demand; an additional investment was approved in October. Going forward, production capacity will be increased incrementally in line with demand trends, and long-term measures will address expanding demand in inspection processes. In new domains, progress in the quantum field and stabilization of price and supply will be pursued, with a medium-term management plan targeting social implementation around 2030. Diversifying raw material procurement and considering the use of recycled materials will enhance stability in Healthcare, and more flexible allocation of resources across businesses will accelerate overall capital efficiency and growth.","jir_financial_highlights":"Revenue: Unknown (First half exceeded initial forecast)\nOperating Income: Unknown (First half exceeded initial forecast; the upside in operating income exceeded the revenue upside)\nOperating Margin (Full Year): 13.2% (Revised upward)\nSemiconductor Business Revenue: 70% year-over-year increase (Year-over-year increase)\nOrder Intake: Unknown (Highest on record for the first half)","jir_category":"","jir_hashtags":"#OXIDECorporation, #Earnings, #Semiconductor, #FaradayRotor","jir_key_figures":"Operating Margin: 13.2% (Full year revised upward)\nSemiconductor Business Revenue: 70% year-over-year increase\nAdditional Investment Amount: approx. 23 hundred million yen (related to Faraday rotors)","jir_meta_title":"OXIDE Corporation \u2014 Earnings Presentation Summary | FY Ending Feb 2027 Q2","jir_meta_description":"Summary of OXIDE Corporation's FY ending Feb 2027 Q2 earnings presentation: drivers of first-half revenue and operating income upside, full-year margin upward revision, semiconductor, healthcare, and quantum domain updates, and planned additional investments and procurement responses.","jir_og_title":"OXIDE Corporation Earnings Summary | FY Ending Feb 2027 Q2","jir_og_description":"OXIDE Corporation revised up its full-year operating margin following a strong first half. Growth in the semiconductor business, additional investments, Healthcare risk countermeasures, and quantum domain strategy are explained. See the full materials for detailed figures.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"H1\\\",\\\"H2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue\\\",\\\"data\\\":[Unknown, Unknown]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"H1\\\",\\\"H2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[Unknown, Unknown]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Gross Margin & Operating Margin\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"H1\\\",\\\"H2\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Gross Margin\\\",\\\"data\\\":[Unknown, Unknown]},{\\\"label\\\":\\\"Operating Margin\\\",\\\"data\\\":[Unknown, 13.2]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Segment Revenue Composition\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"pie\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Semiconductor\\\",\\\"Healthcare\\\",\\\"New Domains\\\"],\\\"datasets\\\":[{\\\"data\\\":[Unknown, Unknown, Unknown]}]},\\\"options\\\":{}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Forecast vs Actual Comparison\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Full Year\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Full Year Forecast\\\",\\\"data\\\":[Unknown]},{\\\"label\\\":\\\"Full Year Actual\\\",\\\"data\\\":[Unknown]}]},\\\"options\\\":{}}\"}]","ir_related_company":57905,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-132407","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n